Conversion Price Adjustment Due to Stock Consolidation


  • 1st CB: conversion price from KRW 886 to 4,430; convertible shares from 4,514,672 to 902,934
  • 2nd CB: conversion price from KRW 924 to 4,620; convertible shares from 2,164,502 to 432,900
  • Reason: stock consolidation (5→1, effective date 2026-04-25)
  • Adjustment applied automatically per bond terms; no separate board resolution
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Adjustment of Conversion Price (1st Series, 2nd Series)
  • Company: Poongjeon Pharmacy (298060)
  • Submission: Poongjeon Pharmacy Co., Ltd.
  • Receipt: 04-27-2026
  • Under KRX KOSDAQ Market Division